1357 related articles for article (PubMed ID: 24214280)
1. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal TP; Hemmingsen C; Wetterslev J
Cochrane Database Syst Rev; 2013 Nov; (11):CD008143. PubMed ID: 24214280
[TBL] [Abstract][Full Text] [Related]
2. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal T; Hemmingsen C; Wetterslev J
Cochrane Database Syst Rev; 2011 Jun; (6):CD008143. PubMed ID: 21678374
[TBL] [Abstract][Full Text] [Related]
3. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
[TBL] [Abstract][Full Text] [Related]
4. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal T; Hemmingsen C; Wetterslev J
BMJ; 2011 Nov; 343():d6898. PubMed ID: 22115901
[TBL] [Abstract][Full Text] [Related]
5. Perioperative glycaemic control for people with diabetes undergoing surgery.
Bellon F; Solà I; Gimenez-Perez G; Hernández M; Metzendorf MI; Rubinat E; Mauricio D
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD007315. PubMed ID: 37526194
[TBL] [Abstract][Full Text] [Related]
6. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
[TBL] [Abstract][Full Text] [Related]
7. Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.
Kähler P; Grevstad B; Almdal T; Gluud C; Wetterslev J; Lund SS; Vaag A; Hemmingsen B
BMJ Open; 2014 Aug; 4(8):e004806. PubMed ID: 25138801
[TBL] [Abstract][Full Text] [Related]
8. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
9. Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus.
Madsen KS; Kähler P; Kähler LKA; Madsbad S; Gnesin F; Metzendorf MI; Richter B; Hemmingsen B
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012368. PubMed ID: 30998259
[TBL] [Abstract][Full Text] [Related]
10. Glucose targets for preventing diabetic kidney disease and its progression.
Ruospo M; Saglimbene VM; Palmer SC; De Cosmo S; Pacilli A; Lamacchia O; Cignarelli M; Fioretto P; Vecchio M; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD010137. PubMed ID: 28594069
[TBL] [Abstract][Full Text] [Related]
11. Perioperative glycaemic control for diabetic patients undergoing surgery.
Buchleitner AM; Martínez-Alonso M; Hernández M; Solà I; Mauricio D
Cochrane Database Syst Rev; 2012 Sep; (9):CD007315. PubMed ID: 22972106
[TBL] [Abstract][Full Text] [Related]
12. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
13. Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Madsen KS; Chi Y; Metzendorf MI; Richter B; Hemmingsen B
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008558. PubMed ID: 31794067
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D supplementation for prevention of mortality in adults.
Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2014 Jan; (1):CD007470. PubMed ID: 24414552
[TBL] [Abstract][Full Text] [Related]
15. Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials.
Seidu S; Achana FA; Gray LJ; Davies MJ; Khunti K
Diabet Med; 2016 Mar; 33(3):280-9. PubMed ID: 26282461
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D supplementation for prevention of cancer in adults.
Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Krstic G; Wetterslev J; Gluud C
Cochrane Database Syst Rev; 2014 Jun; (6):CD007469. PubMed ID: 24953955
[TBL] [Abstract][Full Text] [Related]
17. Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.
Moelands SV; Lucassen PL; Akkermans RP; De Grauw WJ; Van de Laar FA
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD005061. PubMed ID: 30592787
[TBL] [Abstract][Full Text] [Related]
18. Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia.
Areosa Sastre A; Vernooij RW; González-Colaço Harmand M; Martínez G
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003804. PubMed ID: 28617932
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials.
Erpeldinger S; Rehman MB; Berkhout C; Pigache C; Zerbib Y; Regnault F; Guérin E; Supper I; Cornu C; Kassaï B; Gueyffier F; Boussageon R
BMC Endocr Disord; 2016 Jul; 16(1):39. PubMed ID: 27391319
[TBL] [Abstract][Full Text] [Related]
20. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.
Boussageon R; Bejan-Angoulvant T; Saadatian-Elahi M; Lafont S; Bergeonneau C; Kassaï B; Erpeldinger S; Wright JM; Gueyffier F; Cornu C
BMJ; 2011 Jul; 343():d4169. PubMed ID: 21791495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
